drugset / Trial / NCT04500015

Vaginal Isonicotinic Acid Hydrazide Administration Prior to Intrauterine Device Insertion

NCT04500015

Phase 4 Completed 130 enrolled Aswan University Hospital
RandomizedParallel-groupQuadruple-blindPrevention

Summary

To investigate whether vaginal isonicotinic acid hydrazide administered before the levonorgestrel-releasing intrauterine system insertion reduces IUD insertion pain and difficulty in insertion in adolescents and young women.

Timeline

Start
2020-09-01
Primary completion
2021-06-30
Completion
2021-08-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Isonicotinic Acid Hydrazide Unknown 3 unknown Other